Search clinical trials for: Serine Proteinase Inhibitors

Total 71901 results

State University of New York - Upstate Medical...

Terminated

Rivaroxaban Effects in Subjects Who Have Undergone Gastric Bypass Surgery

Gastric Bypass Status

United States
Hong Kong WD Pharmaceutical Co., Limited

Unknown

A Single Dose Bioequivalence Study of WD-1602 Versus Pradaxa® in Healthy Subjects Under Fed Condition

Anticoagulant
Hospital Mutua de Terrassa

Unknown

Dabigatran Study in the Early Phase of Stroke. New Neuroimaging Markers and Biomarkers Study (SEDMAN STUDY) (SEDMAN)

Cardioembolic Stroke

Spain
Capital Medical University

Unknown

The Efficacy and Safety of Dabigatran Etexilate for the Treatment of Cerebral Venous Thrombosis

Cerebral Venous Thrombosis

China
University College, London

Unknown

The Coagulation Cascade in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis | Interstitial Lung Disease | IPF
Boehringer Ingelheim

Withdrawn

Pharmacokinetics, Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 2 Years of Age

Venous Thromboembolism

United States
Boehringer Ingelheim

Completed

Relative Bioavailability of Dabigatran Capsules, Pellets and Oral Solution in Healthy Volunteers

Healthy

Germany
Medical College of Wisconsin

Completed

Gluten and Amylase Trypsin Inhibitors (ATI) Free Diet

Type1diabetes

United States
Michael Kovacs
Ottawa Hospital Research Institute; Jewish General Hospital

Recruiting

Central Venous Catheter (CVC) Associated Deep Vein Thrombosis (DVT) in Cancer Patients

Cancer Patients | Central Venous Catheter Thrombosis | Upper Extremity Thrombosis

Canada
Pfizer
Bristol-Myers Squibb

Active, not recruiting

Treatment Patterns Among Patients With Venous Thromboembolism in the United States

Venous Thromboembolism

United States
Daiichi Sankyo Hong Kong Ltd., a Daiichi Sankyo...

Completed

Edoxaban Treatment in Routine Clinical Practice for Patients With Non-valvular Atrial Fibrillation (ETNA-AF-Hong Kong)

Atrial Fibrillation

Hong Kong
Yale University
Ono Pharmaceutical Co. Ltd

Withdrawn

The Utility of Camostat Mesylate in Patients With COVID-19 Associated Coagulopathy (CAC) and Cardiovascular Complications

COVID-19 | Coagulopathy | Cardiovascular Complication
Instituto de Investigacion Sanitaria La Fe
Bristol-Myers Squibb

Terminated

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Venous Thromboembolism

Spain
Janssen Scientific Affairs, LLC
Bayer

Completed

A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department (MERCURY PE)

Pulmonary Embolism

United States
Hospital Ana Nery
Federal University of Bahia

No longer available

Rivaroxaban in Mechanical Valves: RMV Study (RMV)

Prosthesis; Cardiac, Heart, Functional Disturbance as Result
University of Padova

Terminated

Rivaroxaban in Thrombotic Antiphospholipid Syndrome (TRAPS)

Antiphospholipid Syndrome

Italy
The University of Texas Health Science Center,...

Completed

Safety and Feasibility of Argatroban, Tissue Plasminogen Activator and Intra-arterial Therapy in Stroke (ARTSS-IA)

Stroke | Cerebral Ischemia

United States
University Hospital Inselspital, Berne
University of Lausanne Hospitals

Completed

PK of Rivaroxaban in Bariatric Patients - Extension

Prophylaxis of Venous Thromboembolism

Switzerland
AZ Sint-Jan AV
Onze Lieve Vrouw Hospital

Completed

Dose-finding of Rivaroxaban in Hemodialysis

Chronic Renal Failure

Belgium
Université de Sherbrooke

Terminated

Alpha1 Antitrypsin Aerosol Therapy in Cystic Fibrosis

Cystic Fibrosis

Canada
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

Thromboembolism

Italy, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
Astellas Pharma Inc

Completed

A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects

Healthy Elderly Subject | Pharmacokinetic of YM150

Japan
Ministry of Health, Labour and Welfare, Japan
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia

Heparin-Induced Thrombocytopenia

Japan
Nanjing First Hospital, Nanjing Medical University

Recruiting

Improving Blood Lipid Management in Symptomatic Intracranial Atherosclerotic Stenosis on Clinical Outcome (sICASBLM)

Intracranial Artery Stenosis

China
Techpool Bio-Pharma Co., Ltd.
Children's Hospital of Fudan University; Shanghai Children's Medical Center; Guangzhou... and other collaborators

Unknown

Ulinastatin Injection in in Pediatric Patients Undergoing Open Heart Surgery

Congenital Heart Diseases

China
First Affiliated Hospital Xi'an Jiaotong University

Not yet recruiting

Improvement of Pulmonary Insufficiency After Aortic Dissection With Sivelestat Sodium (IPIADSS)

Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) | Aortic Dissection

China
Boehringer Ingelheim

Completed

Patients' Assessment of Satisfaction for Stroke Prevention in Atrial Fibrillation

Atrial Fibrillation

Taiwan
Boehringer Ingelheim

Completed

Length of Stay in NVAF Patients Hospitalized and Initiated With Dabigatran or Warfarin in Japan

Atrial Fibrillation

Japan
Boehringer Ingelheim

Completed

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Venous Thromboembolism

Italy, Thailand, Russian Federation, Canada, Lithuania, Switzerland
Boehringer Ingelheim

Completed

A Dose Response Study of Dabigatran Etexilate(BIBR 1048) in Pharmacodynamics and Safety in Patients With Non-valvular Atrial Fibrillation in Comparison to Warfarin

Atrial Fibrillation

Japan
Rabin Medical Center
Kamada, Ltd.

Completed

Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes (AAT Extension)

Type 1 Diabetes | Beta Cell Preservation

Israel
Virginia Commonwealth University

Completed

Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction (VCU-Alpha1RT)

Acute Myocardial Infarction

United States
Boehringer Ingelheim

Recruiting

A Study in Europe Based on Medical Records That Looks at the Safety of Dabigatran in Children Below 2 Years of Age Who Have Had a Blood Clot and Are at Risk of Developing Another Blood Clot (DaPaR)

Venous Thromboembolism

Spain, Germany, Netherlands, Czechia, Finland, Sweden
BioCryst Pharmaceuticals

Active, not recruiting

Berotralstat Treatment in Children With Hereditary Angioedema (APeX-P)

Hereditary Angioedema | Pediatric

Spain, Austria, Canada, France, Germany, Israel, Italy, Poland, Romania, United Kingdom
Boehringer Ingelheim

Terminated

Pradaxa (Dabigatran Etexilate) VTE Prevention After Elective Total Hip or Knee Replacement Surgery

Venous Thromboembolism | Arthroplasty, Replacement

Austria
Enrique Ginzburg
Grifols Biologicals, LLC

Terminated

Antithrombin III in Infectious Disease Caused by COVID-19

Covid19 | Antithrombin III Deficiency

United States
Qian Gong

Unknown

Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI)

Coronary Heart Disease
Boehringer Ingelheim

Completed

Safety, Pharmacokinetics and Pharmacodynamics After Multiple Oral Doses of BIBR 1048 MS Capsule in Healthy Japanese Male Subjects

Healthy
University Hospital Tuebingen
Bayer

Withdrawn

Reveal Transition - A Mechanistic Study in Transition / Stabilized Phase of CAD (RevealTrans)

Cardiovascular Diseases

Germany
Brigham and Women's Hospital

Completed

Replication of the EINSTEIN-DVT Anticoagulant Trial in Healthcare Claims Data

Venous Thromboembolism

United States
Brigham and Women's Hospital

Completed

Replication of the EINSTEIN-PE Anticoagulant Trial in Healthcare Claims Data

Pulmonary Embolism

United States
Bristol-Myers Squibb
Pfizer

Completed

Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation

NonValvular Atrial Fibrillation

Japan
Saud Al Babtain Cardiac Center

Completed

Apixaban in Patients With Left Ventricular Thrombus

Left Ventricular Thrombus

Saudi Arabia
University of South Florida
Bristol-Myers Squibb

Completed

Apixaban for Early Prevention of Recurrent Embolic Stroke and Hemorrhagic Transformation (AREST)

Stroke | Atrial Fibrillation | Transient Ischemic Attack

United States
Impatients N.V. trading as myTomorrows
Kamada, Ltd.

No longer available

Early Access Program Using Alpha 1 Antitrypsin Infusion for Patients With Steroid Refractory Acute GvHD After Hematopoietic Stem Cell Transplantation (HSCT)

Alpha 1-Antitrypsin Deficiency | Graft Vs Host Disease | Graft-versus-host-disease | Acute-graft-versus-host Disease | Steroid Refractory Acute Graft Versus Host Disease | Alpha-1 Proteinase Inhibitor | Alpha-1 Protease Inhibitor Deficiency | Acute Graft-Versus-Host Reaction Following Bone Marrow...
Bristol-Myers Squibb
Pfizer

Completed

Multi-center Study to Evaluate the Safety of Apixaban (BMS-562247) in Indian Subjects Undergoing Elective Total Knee Replacement or Total Hip Replacement Surgery

Anticoagulation

India
Swiss Paraplegic Centre Nottwil

Withdrawn

Absorption of Rivaroxaban in Patients With Cervical Spinal Cord Injury (rivaroxaban)

Thromboembolism | Spinal Cord Injuries

Switzerland
Ottawa Hospital Research Institute
Bristol-Myers Squibb; Canadian Institutes of Health Research (CIHR)

Completed

Apixaban for the Prevention of Venous Thromboembolism in Cancer Patients (AVERT)

Cancer | Venous Thromboembolism

Canada
Bristol-Myers Squibb

Withdrawn

Early Post-marketing Study of Eliquis (Apixaban)

Non-valvular Atrial Fibrillation (NVAF)

Mexico
University of North Carolina, Chapel Hill

Completed

A Prospective Pharmacodynamic Study of Rivaroxaban

Blood Clot

United States

Search clinical trials for: Serine Proteinase Inhibitors

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Chile

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations